NasdaqGS - Nasdaq Real Time Price USD

Tourmaline Bio, Inc. (TRML)

15.10
-0.64
(-4.07%)
At close: May 9 at 4:00:02 PM EDT
15.10
0.00
(0.00%)
After hours: May 9 at 4:26:13 PM EDT
All numbers in thousands
Download
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
309,001
210,295
9,098
150
Total Liabilities Net Minority Interest
8,949
5,253
28,830
376
Total Equity Gross Minority Interest
300,052
205,042
-19,732
-226
Total Capitalization
300,052
205,042
-19,732
-226
Common Stock Equity
300,052
205,042
-19,732
-226
Capital Lease Obligations
244
415
504
0
Net Tangible Assets
300,052
205,042
-19,732
-226
Working Capital
259,933
203,872
6,949
-226
Invested Capital
300,052
205,042
-19,732
-76
Tangible Book Value
300,052
205,042
-19,732
-226
Total Debt
244
415
504
150
Share Issued
25,617.81
20,337.57
20,336.77
20,336.77
Ordinary Shares Number
25,617.81
20,337.57
20,336.77
20,336.77
12/31/2021 - 5/7/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SYRE Spyre Therapeutics, Inc.
14.10
+9.64%
 
CNTA Centessa Pharmaceuticals plc
12.30
-0.73%
 
DNTH Dianthus Therapeutics, Inc.
19.59
-5.00%
 
VERA Vera Therapeutics, Inc.
21.71
-1.45%
 
ABVX ABIVAX Société Anonyme
6.71
-2.04%
 
ELVN Enliven Therapeutics, Inc.
18.42
-1.13%
 
PRAX Praxis Precision Medicines, Inc.
38.35
+0.76%
 
PRLD Prelude Therapeutics Incorporated
0.7810
-4.49%
 
SLRN Acelyrin, Inc.
2.3600
-4.07%
 
VALN Valneva SE
6.47
+2.37%